Supplements News and Research

RSS

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.

28 Mar 2019

FDA approves new oral treatment for men with certain forms of hypogonadism

The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism.

27 Mar 2019

FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

27 Mar 2019

Researchers identify metabolic target to prevent or slow progression of heart failure

Researchers with The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have identified a metabolic process in the heart that, if treated, could someday prevent or slow the progression of heart failure.

26 Mar 2019

Eating leafy green vegetables may help maintain muscle strength and mobility

Popeye was on to something. Eating just one cup of leafy green vegetables like spinach each day may help maintain muscle strength and mobility into old age.

25 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

New device approved by FDA for treating patients with moderate-to-severe heart failure

The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.

22 Mar 2019

Air Force develops genetic test to predict mental performance

A research psychologist at the Air Force Research Laboratory can predict your mental performance from a cheek swab or blood sample.

22 Mar 2019

People with peripheral artery disease have lower Omega-3 Index, shows research

New research published in the March 18th edition of Lipids showed that people who have peripheral artery disease have a lower Omega-3 Index compared to those who don't have the disease.

22 Mar 2019

Thermally abused cooking oil may promote progression of breast cancer

A new study in mice suggests that consuming the chemical compounds found in thermally abused cooking oil may trigger genetic changes that promote the progression of late-stage breast cancer.

22 Mar 2019

FDA warns two breast implant makers for failure to comply with post-approval study requirements

Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under their premarket approval orders, to conduct post-approval studies to assess the long-term safety and risks of their silicone gel-filled breast implants.

20 Mar 2019

UTSA professor helps train first responders to detect prescription opioid overdoses

James Bray, professor and chair of the UTSA Department of Psychology, is working on a research project with agencies in Houston to train first responders in how to detect prescription opioid overdoses and provide life-saving outreach services.

20 Mar 2019

FDA approves first drug for treatment of postpartum depression in adult women

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. This is the first drug approved by the FDA specifically for PPD.

20 Mar 2019

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions.

19 Mar 2019

Fish consumption can help prevent asthma, study reveals

A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

19 Mar 2019

FDA grants marketing authorization for new device to help treat carbon monoxide poisoning

The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning.

14 Mar 2019

Green tea lowers obesity, health risks in mice

Green tea cuts obesity and a number of inflammatory biomarkers linked with poor health in a new study.

14 Mar 2019

New insect medium delivers high viable cell density growth and protein yield

FUJIFILM Irvine Scientific, Inc., a world leader in the optimization and manufacture of cell culture media, today announced the introduction of IS Sf Insect medium.

From FUJIFILM Irvine Scientific 13 Mar 2019

Scientists develop GC-MS vitamin D test that costs as little as $0.70

Scientists have developed a rapid, sensitive and cheap test for vitamin D3 levels in blood for clinical assessment, with complete analysis costing $0.70 per sample.

11 Mar 2019

FDA takes action to help reduce risks linked with use of surgical staplers and staples

Today, the U.S. Food and Drug Administration issued a Letter to Health Care Providers to alert them that the agency is aware of an increasing number of medical device reports associated with the use of surgical staplers for internal use and implantable surgical staples - common devices used in many surgeries - and to provide updated recommendations to help reduce risks associated with their use.

11 Mar 2019